Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Non Operating Income (2017 - 2025)

PAVmed has reported Non Operating Income over the past 5 years, most recently at $4.0 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 36.07% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $19.3 million, up 4910.7%, while the annual FY2025 figure was $19.3 million, 73.48% down from the prior year.
  • Non Operating Income for Q4 2025 was $4.0 million at PAVmed, up from -$1.2 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $24.1 million in Q1 2025 and troughed at -$7.6 million in Q2 2025.
  • A 5-year average of -$258235.3 and a median of -$1.2 million in 2024 define the central range for Non Operating Income.
  • Biggest five-year swings in Non Operating Income: crashed 90750.0% in 2023 and later surged 717.46% in 2024.
  • Year by year, Non Operating Income stood at $300000.0 in 2021, then plummeted by 90.33% to $29000.0 in 2022, then plummeted by 3634.48% to -$1.0 million in 2023, then surged by 717.46% to $6.3 million in 2024, then tumbled by 36.07% to $4.0 million in 2025.
  • Business Quant data shows Non Operating Income for PAVM at $4.0 million in Q4 2025, -$1.2 million in Q3 2025, and -$7.6 million in Q2 2025.